Interleukin-10 -1082 G/A gene polymorphisms in Egyptian children with CAP

Medicine (United States)

Volumn 95, Issue 26, 2016, Pages

  Azab, Seham F ^a   Abdalhady, Mohamed A ^a   Elsaadany, Hosam F ^a   Elkomi, Mohamed A ^a   Elhindawy, Eman M ^a   Sarhan, Dina T ^a   Salam, Mohamed M A ^a   Allah, Mayy A N ^a   Emam, Ahmed A ^a   Noah, Maha A ^a   Abdelsalam, Nasser I ^a   Abdellatif, Sawsan H ^a   Rass, Anwar A ^a   Ismail, Sanaa M ^a   Gheith, Tarek ^a   Aziz, Khalid A ^a   Hamed, Mohammed E ^a   Abdelrahman, Hind M ^a   Ahmed, Ahmed R ^a   Nabil, Rehab M ^a   Abdulmaksoud, Rehab S ^a   Yousef, Hala Y ^a   more..

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

children; community acquired pneumonia; gene polymorphisms; interleukin 10

Indexed keywords

INTERLEUKIN 10; IL10 PROTEIN, HUMAN;

ACUTE RESPIRATORY FAILURE; ADOLESCENT; ARTICLE; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEPSIS; BACTERIAL PNEUMONIA; BLOOD; COMMUNITY ACQUIRED INFECTION; EGYPT; GENETIC PREDISPOSITION; GENETICS; PRESCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; EGYPT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INTERLEUKIN-10; MALE; PNEUMONIA, BACTERIAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES;

EID: 84978654090     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004013     Document Type: Article

References (26)

1. McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002;346:429-37
2. Patwari PP, O'Cain P, Goodman DM, et al. Interleukin-1 receptor antagonist intron 2 variable number of tandem repeats polymorphism and respiratory failure in children with community-acquired pneumonia. Pediatr Crit Care Med 2008;96:553-9
3. Gallagher PM, Lowe G, Fitzgerald T, et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 2003;582:154-6
4. Von Dossow V, Rotard K, Redlich U, et al. Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients. Crit Care 2005;9:R662-9
5. Sabat R, Grütz G, Warszawska K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev 2010;215:331-44
6. Cox G. IL-10 enhances resolution of pulmonary inflammation in vivo by promoting apoptosis of neutrophils. Am J Physiol 1996;271: L566-71
7. Donnelly SC, Strieter RM, Reid PT, et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 1996;1253: 191-6
8. Glynn P, Coakley R, Kilgallen I, et al. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax 1999;54: 51-5
9. D'Alfonso S, Rampi M, Rolando V, et al. Momigliano-Richiardi P New polymorphisms in the IL-10 promoter region. Genes Immun 2000;1:231-3
10. Kilpinen S, Huhtala H, Hurme M. The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals. Eur Cytokine Netw 2002;13: 66-71
11. Neuman MI, Monuteaux MC, Scully KJ, et al. Prediction of pneumonia in a pediatric emergency department. Pediatrics 2011; 1282:246-53
12. World Health Organization Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. In WHO V and B 01 35 Pneumonia Vaccine Trials Investigator's Group. Geneva: World Health Organization; 2001:32
13. British Thoracic Society of Standards of Care CommitteeBTS Guidelines for the management of community acquired pneumonia in childhood. Thorax 2011;57:i1-24
14. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992;1016:1481-3
15. Shu Q, Fang X, Chen Q, et al. IL-10 polymorphism is associated with increased incidence of severe sepsis. Chin Med J (Engl) 2003;1161: 1756-9
16. Teepe J, Grigoryan L, Verheij TJ. Determinants of community-acquired pneumonia in children and young adults in primary care. Eur Respir J 2010;355:1113-7
17. Wu CL, Chan MC, Chang GC, et al. Etiology and cytokine expression in patients requiring mechanical ventilation due to severe communityacquired pneumonia. J Formos Med Assoc 2006;105:49-55
18. Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an antiinflammatory drug. Crit Care Med 2002;30:S58-63
19. Doughty L, Carcillo JA, Kaplan S, et al. The compensatory antiinflammatory cytokine interleukin 10 response in pediatric sepsisinduced multiple organ failure. Chest 1998;1136:1625-31
20. Stanilova SA, Miteva LD, Karakolev ZT, et al. Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Med 2006;322:260-6
21. Peñaloza HF, Nieto PA, Muñoz-Durango N, et al. Interleukin-10 plays a key role in the modulation of neutrophils recruitment and lung inflammation during infection by Streptococcus pneumoniae. Immunology 2015;1461:100-12
22. Schaaf BM, Boehmke F, Esnaashari H, et al. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med 2003;1684:476-80
23. Pan W, Zhang AQ, Yue CL, et al. Association between interleukin-10 polymorphisms and sepsis: a meta-analysis. Epidemiol Infect 2015;143: 366-75
24. Gogos CA, Drosou E, Bassaris HP, et al. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000;1811:176-80
25. Lowe PR, Galley HF, Abdel-Fattah A, et al. Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med 2003;31:34-8
26. Montón C, Torres A, El-Ebiary M, et al. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med 1999; 279:1745-53